What is CalAmp's price / sales?

CalAmp (CAMP) reported price / sales of 58.2× in Q1 2026.

How has CalAmp's price / sales changed year-over-year?

CalAmp's price / sales increased by 9.0% year-over-year, from 53.4× to 58.2×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

CalAmp CAMP Price / sales

Price / sales at other companies

Ionis PharmaceuticalsIONS

11.7×+5.0×

Stoke Therapeutics, Inc.STOK

60×+58.2×

MeiraGTx Holdings plcMGTX

8.8×-6.6×

Taysha Gene Therapies, Inc.TSHA

171.9×+132×

CytomX TherapeuticsCTMX

28.6×+28.2×

Sarepta Therapeutics, Inc.SRPT

1×—

Other financials

Income statement

See full

Revenue$1.3M+50.8%

Operating income-$13.1M+0.2%

Net income-$18.3M-47.4%

EPS (diluted)-$0.32+48.4%

Balance sheet

See full

Cash & equivalents$100.8M+97.9%

Total debt$2.1M-73.2%

Total equity$30.9M-40.1%

Total assets$105.5M+68.0%

Cash flow

See full

Operating cash flow-$11.0M+23.1%

CapEx--100%

Free cash flow-$11.0M+24.6%

Valuation

See full

Market cap$226.92M+666%

Enterprise value$128.2M-3,860%

Profitability

See full

Operating margin-1,335.2%-512pp

Net margin-2,193.7%-581pp

FCF margin-1,254%—

Returns & leverage

See full

Return on equity-209.3%—

Debt / equity0.1×-0.1×

Current ratio6.1×-1.9×

Where this comes from

Calculated from CalAmp’s reported figures.

market cap/total revenue=58.2×

Based on the most recent quarter.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CalAmp's price / sales?: CalAmp (CAMP) reported price / sales of 58.2× in Q1 2026.
How has CalAmp's price / sales changed year-over-year?: CalAmp's price / sales increased by 9.0% year-over-year, from 53.4× to 58.2×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.